Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce G Robinson

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Cancer|October 19, 2022
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trialMarcia S Brose, Bruce G Robinson, Steven I Sherman, et al.
Clinical Endocrinology|December 11, 2008
Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumoursAnn I McCormack, Kerrie L McDonald, Anthony J Gill, et al.
Journal of Neuropathology and Experimental Neurology|June 11, 2010
Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survivalKerrie L McDonald, Julie McDonnell, Alessandra Muntoni, et al.
Molecular Cancer Therapeutics|October 15, 2008
Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytomaCathy A Payne, Sanaz Maleki, Marinella Messina, et al.
Oncotarget|October 10, 2015
MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinomaAnthony R Glover, Jing Ting Zhao, Anthony J Gill, et al.
The American Journal of Surgical Pathology|May 27, 2020
A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative NecrosisTalia L Fuchs, Anthony J Nassour, Anthony Glover, et al.
The New England Journal of Medicine|September 21, 2012
Hypoglycemia and risk of death in critically ill patients, Simon Finfer, Bette Liu, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2007
IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patientsKerrie L McDonald, Maree G O'Sullivan, Jonathon F Parkinson, et al.
The American Journal of Surgical Pathology|September 17, 2016
NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2Jessica Reagh, Martyn Bullock, Juliana Andrici, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocationThomas J Giordano, Amy Y M Au, Rork Kuick, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Cancer|October 19, 2022
Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trialMarcia S Brose, Bruce G Robinson, Steven I Sherman, et al.
Clinical Endocrinology|December 11, 2008
Low O6-methylguanine-DNA methyltransferase (MGMT) expression and response to temozolomide in aggressive pituitary tumoursAnn I McCormack, Kerrie L McDonald, Anthony J Gill, et al.
Journal of Neuropathology and Experimental Neurology|June 11, 2010
Presence of alternative lengthening of telomeres mechanism in patients with glioblastoma identifies a less aggressive tumor type with longer survivalKerrie L McDonald, Julie McDonnell, Alessandra Muntoni, et al.
Molecular Cancer Therapeutics|October 15, 2008
Loss of prostaglandin D2 synthase: a key molecular event in the transition of a low-grade astrocytoma to an anaplastic astrocytomaCathy A Payne, Sanaz Maleki, Marinella Messina, et al.
Oncotarget|October 10, 2015
MicroRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinomaAnthony R Glover, Jing Ting Zhao, Anthony J Gill, et al.
The American Journal of Surgical Pathology|May 27, 2020
A Proposed Grading Scheme for Medullary Thyroid Carcinoma Based on Proliferative Activity (Ki-67 and Mitotic Count) and Coagulative NecrosisTalia L Fuchs, Anthony J Nassour, Anthony Glover, et al.
The New England Journal of Medicine|September 21, 2012
Hypoglycemia and risk of death in critically ill patients, Simon Finfer, Bette Liu, et al.
Journal of Neuropathology and Experimental Neurology|May 8, 2007
IQGAP1 and IGFBP2: valuable biomarkers for determining prognosis in glioma patientsKerrie L McDonald, Maree G O'Sullivan, Jonathon F Parkinson, et al.
The American Journal of Surgical Pathology|September 17, 2016
NRASQ61R Mutation-specific Immunohistochemistry Also Identifies the HRASQ61R Mutation in Medullary Thyroid Cancer and May Have a Role in Triaging Genetic Testing for MEN2Jessica Reagh, Martyn Bullock, Juliana Andrici, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocationThomas J Giordano, Amy Y M Au, Rork Kuick, et al.
Pageof 15